New cream targets root cause of devastating skin disease
NCT ID NCT05211830
Summary
This study tested a new skin cream called SXR1096 for people with Netherton Syndrome, a rare and severe genetic skin condition with no specific treatment. For one month, participants applied the active cream and a placebo cream to different areas of their skin. The main goals were to see if the cream was safe and if it could improve the redness and scaling of the skin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NETHERTON SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska Hospital, Huddinge
Stockholm, Sweden
-
Medical University Innsbruck, Tirol Kliniken
Innsbruck, Austria
-
Necker Hospital
Paris, France
-
Saint Louis Hospital
Paris, 75010, France
-
University of Freiburg
Freiburg im Breisgau, Germany
Conditions
Explore the condition pages connected to this study.